This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Congestive heart failure
  • /
  • Levosimendan, a novel Ca2+ sensitizer, activates t...
Journal

Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes

Read time: 1 mins
Published:27th Aug 1997
Author: <p>Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N.</p>
Availability: Pay for access, or by subscription
Ref.:Eur J Pharmacol. 1997;333:249�59.
DOI:10.1016/S0014-2999(97)01108-4
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest